Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 08 Aug 2024

Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience

in Respiratory Pharmacology

Anna Agnese Stanziola
Claudio Candia
Gerardo Nazzaro
Antonio Caso
Claudia Merola
Lorena Gallotti
Mauro Maniscalco

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449220

3,010 views
3 citations

Original Research

Published on 07 Aug 2024

CKD-497 inhibits NF-kB signaling and ameliorates inflammation and pulmonary fibrosis in ovalbumin-induced asthma and particulate matter-induced airway inflammatory diseases

in Respiratory Pharmacology

Hyejeong Kim
Jihye Choi
Jaeok Seo
Hyungjoon Lim
Sung Kwon Kang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428567

2,441 views

Review

Published on 23 Jul 2024

Role and regulators of N6-methyladenosine (m6A) RNA methylation in inflammatory subtypes of asthma: a comprehensive review

in Respiratory Pharmacology

Ge Gao
Yu Qiu Hao
Chen Wang
Peng Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360607

2,096 views
3 citations

Original Research

Published on 18 Jul 2024

Effect of different sedatives on the prognosis of patients with mechanical ventilation: a retrospective cohort study based on MIMIC-IV database

in Respiratory Pharmacology

Xiaoding Shi
Jiaxing Zhang
Yufei Sun
Meijun Chen
Fei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1301451

4,470 views

Original Research

Published on 18 Jul 2024

Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study

in Respiratory Pharmacology

Saima Mukhtar
Nakhshab Choudhry
Saqib Saeed
Asif Hanif
Aamir J. Gondal
Nighat Yasmin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376394

1,356 views

Editorial

Published on 09 Jul 2024

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery

in Respiratory Pharmacology

Poonam Arora
Lalit Mohan Nainwal
Seyyed Shamsadin Athari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419138

1,020 views

Methods

Published on 01 Jul 2024

A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency

in Respiratory Pharmacology

Celine H. Chen
Helena Crisford
Aaron Scott
Elizabeth Sapey
Robert A. Stockley

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421598

1,689 views
1 citation

Original Research

Published on 24 Jun 2024

Tropine exacerbates the ventilatory depressant actions of fentanyl in freely-moving rats

in Respiratory Pharmacology

Paulina M. Getsy
Walter J. May
Alex P. Young
Santhosh M. Baby
Gregory A. Coffee
James N. Bates
Yee-Hsee Hsieh
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405461

1,173 views
2 citations

Case Report

Published on 04 Jun 2024

Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review

in Respiratory Pharmacology

Xiaofei Gu
Yonghong Zhong
Huaqiong Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410684

2,211 views
2 citations

Correction

Published on 28 May 2024

Corrigendum: Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats

in Respiratory Pharmacology

Nicole Reyne
Patricia Cmielewski
Alexandra McCarron
Ronan Smith
Elena Schneider-Futschik
Nina Eikelis
Piraveen Pirakalathanan
David Parsons
Martin Donnelley

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428213

816 views

Clinical Trial

Published on 10 May 2024

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

in Respiratory Pharmacology

Ling Zhou
Yan Deng
Kui Liu
Huiguo Liu
Wei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380939

2,660 views
2 citations

Original Research

Published on 10 May 2024

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma

in Respiratory Pharmacology

Xiaoyue Zeng
Lu Xue
Wei Li
Ping Zhao
Weiwei Chen
Wenyi Wang
Jinhua Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345070

1,731 views

Original Research

Published on 09 May 2024

Vitamin D level in COVID-19 patients has positive correlations with autophagy and negative correlations with disease severity

in Respiratory Pharmacology

Hongna Dong
Yuqiu Hao
Peng Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388348

1,806 views

Original Research

Published on 07 May 2024

Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model

in Respiratory Pharmacology

Juliana Morelli Lopes Gonçalves João
Jéssica Anastácia Silva Barbosa
Luana Laura Sales da Silva
Silvia Fukuzaki
Elaine Cristina de Campos
Leandro do Nascimento Camargo
Tabata Maruyama dos Santos
Suellen Karoline Moreira Bezerra
Francine Maria de Almeida
Beatriz Mangueira Saraiva-Romanholo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1282870

2,201 views
1 citation

Editorial

Published on 25 Apr 2024

Editorial: Pathogen targeting in chronic respiratory diseases: prevention, therapy and management

in Respiratory Pharmacology

Shakti D. Shukla
Kamal Dua
Ronan F. O’Toole

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407616

892 views

Original Research

Published on 18 Apr 2024

Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing

in Respiratory Pharmacology

Santhosh M. Baby
Walter J. May
Paulina M. Getsy
Gregory A. Coffee
Tej Nakashe
James N. Bates
Alan Levine
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381073

2,871 views
6 citations